Scarica l'app Stockscreener
28.22
1.18%
0.33
Dopo l'orario di chiusura:
28.80
0.58
+2.06%
Precedente Chiudi:
$27.89
Aprire:
$28.26
Volume 24 ore:
2.17M
Relative Volume:
1.65
Capitalizzazione di mercato:
$4.17B
Reddito:
$15.06M
Utile/perdita netta:
$-242.05M
Rapporto P/E:
-15.50
EPS:
-1.8204
Flusso di cassa netto:
$-181.28M
1 W Prestazione:
-1.71%
1M Prestazione:
+4.63%
6M Prestazione:
+22.64%
1 anno Prestazione:
+78.49%
Intervallo 1D:
$27.86
$29.47
Intervallo di 1 settimana:
$25.17
$29.47
Portata 52W:
$9.60
$30.58
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
Nome
Centessa Pharmaceuticals Plc Adr
Settore
Industria
Telefono
44 7391 789784
Indirizzo
3RD FLOOR, ALTRINCHAM, CHESHIRE
Compare CNTA vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
28.22 | 4.12B | 15.06M | -242.05M | -181.28M | -1.8204 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-24 | Iniziato | Wolfe Research | Outperform |
| 2025-12-10 | Ripresa | Oppenheimer | Outperform |
| 2025-10-28 | Iniziato | Stephens | Overweight |
| 2025-09-03 | Iniziato | Wells Fargo | Overweight |
| 2025-08-29 | Ripresa | Oppenheimer | Outperform |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-05-28 | Iniziato | Needham | Buy |
| 2025-05-08 | Iniziato | Chardan Capital Markets | Buy |
| 2025-03-31 | Iniziato | Piper Sandler | Overweight |
| 2025-01-07 | Iniziato | TD Cowen | Buy |
| 2024-09-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | Iniziato | B. Riley Securities | Buy |
| 2024-07-18 | Iniziato | Oppenheimer | Outperform |
| 2023-11-15 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-10-26 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | Iniziato | Evercore ISI | Outperform |
| 2023-06-12 | Iniziato | Guggenheim | Buy |
| 2023-03-17 | Iniziato | SVB Securities | Outperform |
| 2022-08-12 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | Iniziato | BMO Capital Markets | Outperform |
| 2022-06-03 | Downgrade | Jefferies | Buy → Hold |
| 2022-02-11 | Iniziato | Goldman | Neutral |
Mostra tutto
Centessa Pharmaceuticals Plc Adr Borsa (CNTA) Ultime notizie
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Karen Anderson Sells 64,768 Shares - MarketBeat
Karen Anderson Sells 10,043 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock - MarketBeat
Karen M. Anderson sells ADRs; CNTA (NASDAQ: CNTA) Form 144 notice - Stock Titan
Cinctive Capital Management LP Purchases New Stake in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
[144] Centessa Pharmaceuticals plc SEC Filing - Stock Titan
First Light Asset Management LLC Sells 657,595 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Foresite Capital Management VI LLC Buys 60,640 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Holdings Cut by Commodore Capital LP - MarketBeat
Centessa Pharmaceuticals CEO Touts ORX750 as Best-in-Class as Registration Studies Nearing Start - Yahoo Finance
Avoro Capital Advisors LLC Buys 5,808,080 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Gregory Weinhoff Sells 73,196 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Karen Anderson Sells 120,029 Shares - MarketBeat
CNTA (NASDAQ: CNTA) insider files Form 144 to sell 120,029 ADRs valued $3.10M - Stock Titan
Capital World Investors Has $16.61 Million Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Sold by American Century Companies Inc. - Defense World
American Century Companies Inc. Has $27.08 Million Stock Position in BJ’s Restaurants, Inc. $BJRI - Defense World
Centessa Pharmaceuticals Teases ORX750 Phase II Update, Registrational Study Start at Conference - Yahoo Finance
Blue Owl Capital Holdings LP Reduces Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Royce & Associates LP Acquires New Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
CNTA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
TD Asset Management Inc Trims Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition - AOL.com
Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline - The Motley Fool
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Sold by Aberdeen Group plc - Defense World
Norsk Hydro ASA (OTCMKTS:NHYDY) Cut to “Strong Sell” at Kepler Capital Markets - Defense World
Eagle Health Investments LP Makes New Investment in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Orexin-2 Receptor Data Reinforces a Positive Outlook for Centessa (CNTA) - Finviz
Caprock Group LLC Buys New Stake in iShares Bitcoin Trust ETF $IBIT - Defense World
Centessa Pharmaceuticals CEO Teases “Transformational” 2026 as ORX750 Nears Registrational Trials - Yahoo Finance
Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap DownWhat's Next? - MarketBeat
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells 1,010 Shares of Stock - MarketBeat
WCM Investment Management LLC Increases Stock Position in Novo Nordisk A/S $NVO - Defense World
Best Infrastructure Stocks To Watch Now – January 31st - Defense World
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Federated Hermes Inc. Purchases Shares of 1,749,650 Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Centessa Pharmaceuticals (CNTA) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Truist Hikes Centessa (CNTA) PT to $33 While Maintaining Consistent 2026 Thesis - Finviz
A Look At Centessa Pharmaceuticals (CNTA) Valuation After New Analyst Focus On Orexin Pipeline Expansion - Sahm
Needham Hikes Centessa (CNTA) PT to $38 on High Potential for ORX-750 Trial Success and M&A Appeal - Finviz
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Armistice Capital LLC Lowers Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
oracle, visa among market cap stock movers on thursday By Investing.com - Investing.com UK
oracle, visa among market cap stock movers on thursday - Investing.com India
Russell Investments Group Ltd. Has $1.85 Million Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals Plc Adr Azioni (CNTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):